EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis

Hanan Abushwereb, Fatma Ertimi, Souad Hashad

Journal of Clinical Pediatrics · 16.06.2026 · 17 (1)

DOI: 10.52338/jocp.2026.5782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pediatrics, online erschienen am 16.06.2026. Verfasst von Hanan Abushwereb und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Juvenile idiopathic arthritis (JIA) is treated with methotrexate (MTX), but its adverse effects can lead to treatment discontinuation. This study investigates the incidence and risk factors of MTX side effects in JIA patients.

Methods

A retrospective study of 123 JIA patients (aged 1-18 years) treated with MTX between 2002 and 2020 was conducted.

Results

78.9% of patients experienced MTX side effects. Younger patients (

Zitieren

APA

Abushwereb, H., Ertimi, F., & Hashad, S. (2026). Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis. Journal of Clinical Pediatrics, 17(1). https://doi.org/10.52338/jocp.2026.5782

Vancouver

Abushwereb H, Ertimi F, Hashad S. Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis. Journal of Clinical Pediatrics. 2026;17(1). doi:10.52338/jocp.2026.5782

BibTeX
@article{Abushwereb2026,
  author = {Abushwereb, Hanan and Ertimi, Fatma and Hashad, Souad},
  title = {Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis},
  journal = {Journal of Clinical Pediatrics},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.52338/jocp.2026.5782}
}
Kostenlos starten →